Jaguar Health announces investor webcast on August 19
The event will cover Q2 2026 financials and corporate updates.
Latest Jaguar Health News & Updates
See the latest news and media coverage for Jaguar Health. We track all announcements, press releases, and industry mentions in real time, all in one place.
Plant-based prescription medicine developer for gastrointestinal diseases
jaguar.health- Headquarters
- San Francisco, United States
- Founded year
- 2013
- Company type
- Public company
- Number of employees
- 30–50
- Industry
- Pharmaceuticals
Last updated
Latest news about Jaguar Health
In short: Jaguar Health advanced its crofelemer program, launched new canine products, and secured a significant licensing deal with Future Pak.
Company announcements
Jaguar Health receives non-dilutive payment from Future Pak
The company satisfied conditions for the $2 million holdback related to commercial licenses for Mytesi and Canalevia-CA1.
Jaguar Health completes NADA submission for full FDA approval
The application covers Crofelemer (Canalevia-CA1) for treating chemotherapy-induced diarrhea in dogs. Pivotal study results showed statistically significant efficacy and owner satisfaction.
Jaguar Health explores strategic alternatives aligned with NDA filing
The board initiated the process to maximize stockholder value for its crofelemer intestinal failure program, considering mergers or partnerships.
Media coverage
JAGX Stock Explodes As Mytesi Win Collides With Reverse Split
Jaguar Health Inc. faces heightened downside risk as critical pipeline and funding concerns emerge, with stocks have been trading down by -52.12 percent. Key Takeaways...
JAGX Stock Soars Over 10% Premarket After Best Day In Over 8 Years: What’s Driving The Surge?
Jaguar Health aims to file for approval of its Crofelemer powder treatment for pediatric MVID in...
Jaguar Health stock plunges Wednesday: What's happening?
Jaguar Health Inc. JAGX shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers. Jaguar Health stock is...
Jaguar Health Receives Fee Waivers from FDA
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for...
Never miss news about Jaguar Health
Track Jaguar Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Jaguar Health competitors & trending companies
Browse news for competitors to Jaguar Health and other trending companies.